MedPath

Effect of Smart Phone Application on the Individualized Management of Chinese Diabetic Patients

Not Applicable
Conditions
Diabetes Mellitus
Interventions
Device: Welltang App
Registration Number
NCT02589730
Lead Sponsor
Shanghai Geping Information Technology Company
Brief Summary

The purpose of this study was to explore a model suitable for the individualized diabetic management based on the mobile application coaching and demonstrate its effect among the diabetic mellitus population.

Detailed Description

The enrolled patients will be randomly divided into three groups: group of online self management, group of online mutual management and the control group. The estimated sample size was 78 patients for each group. All the patients attend two follow-up visits at the hospital, after 3 and 6 months. The data will be collected by a full-time recorder and analyzed using specific statistical software. The enumeration data are analyzed by chi-square test, while the measurement data are analyzed by one-way ANOVA.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
234
Inclusion Criteria
  • Physician diagnosis of DM for more than 6 months;
  • Glycated hemoglobin more than or equal to 8% within 3 months;
  • Age:18-65 years.
Exclusion Criteria
  • Insulin pump users;
  • Pregnant;
  • Active substance, alcohol, or drug abuser;
  • Psychotic or schizophrenic under active care;
  • Severe hearing or visual impairment and other complications;
  • Drug users (such as glucocorticoid or thyroid hormone) 3 months before the enrollment;
  • No smartphone access.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
online mutual managementWelltang AppThe patients received the online coaching of a doctor and diabetes educator via smart phone based welltang app.
online self-managementWelltang AppThe patients received the online coaching of a doctor alone via smart phone based welltang app.
Primary Outcome Measures
NameTimeMethod
change in glycated hemoglobin levelssix months
Secondary Outcome Measures
NameTimeMethod
change of hepatic functionsix months
change in lipid profile levelssix months
change of urinary albumin creatinine ratesix months
change of blood creatinesix months
change of blood urea nitrogensix months
change in scores measured by MKTsix months

Trial Locations

Locations (1)

Shanghai Six People's Hospital

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath